THE / TRY

THE / USDT

THE / USDC

KMNO / USDC

KMNO / USDT

W / BTC

MAV / BTC

PROM / USDT

W / FDUSD

W / TRY

SLF / BTC

SLF / USDC

SLF / USDT

SLF / TRY

OG / USDT

OG / TRY

OG / BTC

MITO / FDUSD

DOLO / BNB

RVN / BTC

URBAN COMPANY LIMITED

QMS MEDI LTD

SMARTEN POWER SYSTEMS LTD

TRF LIMITED

SUPERHOUSE LIMITED

IRM ENERGY LIMITED

BRAND CONCEPTS LIMITED

N R VANDANA TEX IND LTD

ANLON HEALTHCARE LIMITED

PROZONE REALTY LIMITED

DE NEERS TOOLS LIMITED

HAPPY SQUARE OUTSOURC S L

ENFUSE SOLUTIONS LIMITED

SHRADHA INFRAPROJECTS LTD

MANGAL ELECTRICAL IND L

SHARP CHUCKS N MACHINES L

ZODIAC CLOTHING CO. LTD.

NAGREEKA EXPORTS LTD.

SHREE RAMA NEWSPRINT LTD

SARVESHWAR FOODS LIMITED

Click here to get full coverage on Indoco Remedies Shows Strong Rebound Amid Broader Small-Cap Market Gains - Markets Mojo

Indoco Remedies Shows Strong Rebound Amid Broader Small-Cap Market Gains  Markets Mojo

Indoco Remedies Shows Strong Rebound Amid Broader Small-Cap Market Gains - Markets Mojo

Click here to get full coverage on Indoco Remedies AGM Approves ₹0.20 Final Dividend Per Share - TradingView

Indoco Remedies AGM Approves ₹0.20 Final Dividend Per Share  TradingView

Indoco Remedies AGM Approves ₹0.20 Final Dividend Per Share - TradingView

Click here to get full coverage on Here's Why Shareholders Should Examine Indoco Remedies Limited's (NSE:INDOCO) CEO Compensation Package More Closely - simplywall.st

Here's Why Shareholders Should Examine Indoco Remedies Limited's (NSE:INDOCO) CEO Compensation Package More Closely  simplywall.st

Here's Why Shareholders Should Examine Indoco Remedies Limited's (NSE:INDOCO) CEO Compensation Package More Closely - simplywall.st

Click here to get full coverage on Indoco Remedies Executes Sale and Leaseback Agreement for Strategic Asset Management - TipRanks

Indoco Remedies Executes Sale and Leaseback Agreement for Strategic Asset Management  TipRanks

Indoco Remedies Executes Sale and Leaseback Agreement for Strategic Asset Management - TipRanks

Click here to get full coverage on Indoco Remedies Share Price Today Up 9% - Equitymaster

Indoco Remedies Share Price Today Up 9%  Equitymaster

Indoco Remedies Share Price Today Up 9% - Equitymaster

Click here to get full coverage on Acute Respiratory Distress Syndrome Market Forecast and Company Analysis Report 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun, Teva - GlobeNewswire

Acute Respiratory Distress Syndrome Market Forecast and Company Analysis Report 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun, Teva  GlobeNewswire

Acute Respiratory Distress Syndrome Market Forecast and Company Analysis Report 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun, Teva - GlobeNewswire

Click here to get full coverage on Acute Respiratory Distress Syndrome Market Forecast and Company Analysis Report 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun, Teva - uk.finance.yahoo.com

Acute Respiratory Distress Syndrome Market Forecast and Company Analysis Report 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun, Teva  uk.finance.yahoo.com

Acute Respiratory Distress Syndrome Market Forecast and Company Analysis Report 2025-2033 Featuring Ajanta, Akorn, Alembic, Cipla, Indoco Remedies, J&J, Novartis, Ocular Therapeutix, Sun, Teva - uk.finance.yahoo.com

Click here to get full coverage on Indoco Remedies secures USFDA approval for Allopurinol Tablets to lower high uric acid levels in blood - Medical Dialogues

Indoco Remedies secures USFDA approval for Allopurinol Tablets to lower high uric acid levels in blood  Medical Dialogues

Indoco Remedies secures USFDA approval for Allopurinol Tablets to lower high uric acid levels in blood - Medical Dialogues

Click here to get full coverage on Indoco Remedies receives USFDA approval for Rivaroxaban Tablets - Business Standard

Indoco Remedies receives USFDA approval for Rivaroxaban Tablets  Business Standard

Indoco Remedies receives USFDA approval for Rivaroxaban Tablets - Business Standard

Click here to get full coverage on Nirmal Bang Remains Structurally Positive On Indoco Remedies; Maintains Hold Rating — Check Target Price - NDTV Profit

Nirmal Bang Remains Structurally Positive On Indoco Remedies; Maintains Hold Rating — Check Target Price  NDTV Profit

Nirmal Bang Remains Structurally Positive On Indoco Remedies; Maintains Hold Rating — Check Target Price - NDTV Profit

Click here to get full coverage on Indoco Remedies' AnaCipher says USFDA has completed inspection of Hyderabad facility - CNBC TV18

Indoco Remedies' AnaCipher says USFDA has completed inspection of Hyderabad facility  CNBC TV18

Indoco Remedies' AnaCipher says USFDA has completed inspection of Hyderabad facility - CNBC TV18

Click here to get full coverage on Indoco Remedies Experiences Notable Rebound Amid Broader Small-Cap Market Strength - Markets Mojo

Indoco Remedies Experiences Notable Rebound Amid Broader Small-Cap Market Strength  Markets Mojo

Indoco Remedies Experiences Notable Rebound Amid Broader Small-Cap Market Strength - Markets Mojo

Click here to get full coverage on Indoco Remedies Limited (NSE:INDOCO) Soars 27% But It's A Story Of Risk Vs Reward - simplywall.st

Indoco Remedies Limited (NSE:INDOCO) Soars 27% But It's A Story Of Risk Vs Reward  simplywall.st

Indoco Remedies Limited (NSE:INDOCO) Soars 27% But It's A Story Of Risk Vs Reward - simplywall.st

Click here to get full coverage on Indoco Remedies gets USFDA nod for venous thromboembolism drug Rivaroxaban - Medical Dialogues

Indoco Remedies gets USFDA nod for venous thromboembolism drug Rivaroxaban  Medical Dialogues

Indoco Remedies gets USFDA nod for venous thromboembolism drug Rivaroxaban - Medical Dialogues

Click here to get full coverage on Indoco Remedies edges higher after receiving EU GMP certificate for Goa-based manufacturing facility - Business Standard

Indoco Remedies edges higher after receiving EU GMP certificate for Goa-based manufacturing facility  Business Standard

Indoco Remedies edges higher after receiving EU GMP certificate for Goa-based manufacturing facility - Business Standard

Click here to get full coverage on Earnings Update: Here's Why Analysts Just Lifted Their Indoco Remedies Limited (NSE:INDOCO) Price Target To ₹259 - simplywall.st

Earnings Update: Here's Why Analysts Just Lifted Their Indoco Remedies Limited (NSE:INDOCO) Price Target To ₹259  simplywall.st

Earnings Update: Here's Why Analysts Just Lifted Their Indoco Remedies Limited (NSE:INDOCO) Price Target To ₹259 - simplywall.st

Click here to get full coverage on Indoco Remedies Experiences Evaluation Shift Amidst Mixed Technical Indicators and Performance Challenges - Markets Mojo

Indoco Remedies Experiences Evaluation Shift Amidst Mixed Technical Indicators and Performance Challenges  Markets Mojo

Indoco Remedies Experiences Evaluation Shift Amidst Mixed Technical Indicators and Performance Challenges - Markets Mojo

Click here to get full coverage on Indoco Remedies (NSE:INDOCO) shareholder returns have been notable, earning 60% in 5 years - simplywall.st

Indoco Remedies (NSE:INDOCO) shareholder returns have been notable, earning 60% in 5 years  simplywall.st

Indoco Remedies (NSE:INDOCO) shareholder returns have been notable, earning 60% in 5 years - simplywall.st

Click here to get full coverage on Private companies who have a significant stake must be disappointed along with institutions after Indoco Remedies Limited's (NSE:INDOCO) market cap dropped by ₹2.5b - simplywall.st

Private companies who have a significant stake must be disappointed along with institutions after Indoco Remedies Limited's (NSE:INDOCO) market cap dropped by ₹2.5b  simplywall.st

Private companies who have a significant stake must be disappointed along with institutions after Indoco Remedies Limited's (NSE:INDOCO) market cap dropped by ₹2.5b - simplywall.st

Click here to get full coverage on Indoco Remedies Subsidiary Launches Generic Drug In UK - NDTV Profit

Indoco Remedies Subsidiary Launches Generic Drug In UK  NDTV Profit

Indoco Remedies Subsidiary Launches Generic Drug In UK - NDTV Profit

Click here to get full coverage on Indoco Remedies gets warning letter from USFDA for Goa plant - The Economic Times

Indoco Remedies gets warning letter from USFDA for Goa plant  The Economic Times

Indoco Remedies gets warning letter from USFDA for Goa plant - The Economic Times

Click here to get full coverage on Indoco Remedies CRO AnaCipher gets one Form 483 from USFDA - Medical Dialogues

Indoco Remedies CRO AnaCipher gets one Form 483 from USFDA  Medical Dialogues

Indoco Remedies CRO AnaCipher gets one Form 483 from USFDA - Medical Dialogues

Click here to get full coverage on Indoco Remedies Q4 Results: Shares fall 7% as company reports loss, revenue drops 12% - CNBC TV18

Indoco Remedies Q4 Results: Shares fall 7% as company reports loss, revenue drops 12%  CNBC TV18

Indoco Remedies Q4 Results: Shares fall 7% as company reports loss, revenue drops 12% - CNBC TV18

Click here to get full coverage on Indoco Remedies gains on receiving USFDA nod for Rivaroxaban tablets - Business Standard

Indoco Remedies gains on receiving USFDA nod for Rivaroxaban tablets  Business Standard

Indoco Remedies gains on receiving USFDA nod for Rivaroxaban tablets - Business Standard

Click here to get full coverage on Indoco receives EU GMP certificate for its sterile manufacturing facility in Goa - Indian Pharma Post

Indoco receives EU GMP certificate for its sterile manufacturing facility in Goa  Indian Pharma Post

Indoco receives EU GMP certificate for its sterile manufacturing facility in Goa - Indian Pharma Post

Click here to get full coverage on Sell Indoco Remedies Shares Maintains Dolat Capital Post Q1 Results, Sees 36% Downside — Heres Why - NDTV Profit

Sell Indoco Remedies Shares Maintains Dolat Capital Post Q1 Results, Sees 36% Downside — Heres Why  NDTV Profit

Sell Indoco Remedies Shares Maintains Dolat Capital Post Q1 Results, Sees 36% Downside — Heres Why - NDTV Profit

Click here to get full coverage on Indoco Remedies shares rise as it receives EU 'Good Manufacturing Practices' certificate - CNBC TV18

Indoco Remedies shares rise as it receives EU 'Good Manufacturing Practices' certificate  CNBC TV18

Indoco Remedies shares rise as it receives EU 'Good Manufacturing Practices' certificate - CNBC TV18

Click here to get full coverage on What drove Indoco Remedies share price 6% higher today? Top details inside - Business Standard

What drove Indoco Remedies share price 6% higher today? Top details inside  Business Standard

What drove Indoco Remedies share price 6% higher today? Top details inside - Business Standard

Click here to get full coverage on Indoco Remedies gains after receiving USFDA nod for Allopurinol drug - Business Standard

Indoco Remedies gains after receiving USFDA nod for Allopurinol drug  Business Standard

Indoco Remedies gains after receiving USFDA nod for Allopurinol drug - Business Standard

Click here to get full coverage on Indoco Remedies rises 6% on EU GMP certificate, trims gains after Q1 show - Business Standard

Indoco Remedies rises 6% on EU GMP certificate, trims gains after Q1 show  Business Standard

Indoco Remedies rises 6% on EU GMP certificate, trims gains after Q1 show - Business Standard

Click here to get full coverage on Here's why Indoco Remedies shares were under pressure on March 11; details - Business Standard

Here's why Indoco Remedies shares were under pressure on March 11; details  Business Standard

Here's why Indoco Remedies shares were under pressure on March 11; details - Business Standard

Click here to get full coverage on Indoco Remedies Secures USFDA Approval for Allopurinol Tablets USP 200 mg - HDFC Sky

Indoco Remedies Secures USFDA Approval for Allopurinol Tablets USP 200 mg  HDFC Sky

Indoco Remedies Secures USFDA Approval for Allopurinol Tablets USP 200 mg - HDFC Sky

Click here to get full coverage on Goa Leaders Slam Indoco Pharma for Advertising Jobs Outside State, Demand Immediate Withdrawal - heraldgoa.in

Goa Leaders Slam Indoco Pharma for Advertising Jobs Outside State, Demand Immediate Withdrawal  heraldgoa.in

Goa Leaders Slam Indoco Pharma for Advertising Jobs Outside State, Demand Immediate Withdrawal - heraldgoa.in

Click here to get full coverage on Indoco Remedies reports net loss of ₹35.6 crore in Q1, margin contracts - CNBC TV18

Indoco Remedies reports net loss of ₹35.6 crore in Q1, margin contracts  CNBC TV18

Indoco Remedies reports net loss of ₹35.6 crore in Q1, margin contracts - CNBC TV18

Click here to get full coverage on Indoco Remedies drops 4% on weak Q3 performance; revenue falls 11% YoY - Business Standard

Indoco Remedies drops 4% on weak Q3 performance; revenue falls 11% YoY  Business Standard

Indoco Remedies drops 4% on weak Q3 performance; revenue falls 11% YoY - Business Standard

Click here to get full coverage on Indoco Remedies Faces Operational Challenges Amid Shift to Neutral Evaluation Score - Markets Mojo

Indoco Remedies Faces Operational Challenges Amid Shift to Neutral Evaluation Score  Markets Mojo

Indoco Remedies Faces Operational Challenges Amid Shift to Neutral Evaluation Score - Markets Mojo

Click here to get full coverage on Indoco Remedies gets Certificate of EU GMP Compliance for Goa sterile drug product manufacturing facility - Medical Dialogues

Indoco Remedies gets Certificate of EU GMP Compliance for Goa sterile drug product manufacturing facility  Medical Dialogues

Indoco Remedies gets Certificate of EU GMP Compliance for Goa sterile drug product manufacturing facility - Medical Dialogues

Click here to get full coverage on Indoco Remedies Awarded EU GMP Certification for Sterile Drug Manufacturing at Goa Plant II - Machine Maker

Indoco Remedies Awarded EU GMP Certification for Sterile Drug Manufacturing at Goa Plant II  Machine Maker

Indoco Remedies Awarded EU GMP Certification for Sterile Drug Manufacturing at Goa Plant II - Machine Maker

Click here to get full coverage on Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y - Moneycontrol

Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y  Moneycontrol

Indoco Remedies Consolidated June 2025 Net Sales at Rs 437.89 crore, up 1.48% Y-o-Y - Moneycontrol

Click here to get full coverage on Indoco Remedies shares fall after USFDA warning letter over Goa facility - Moneycontrol

Indoco Remedies shares fall after USFDA warning letter over Goa facility  Moneycontrol

Indoco Remedies shares fall after USFDA warning letter over Goa facility - Moneycontrol

Click here to get full coverage on Indoco Remedies Faces Significant Stock Decline Amid Broader Market Challenges - Markets Mojo

Indoco Remedies Faces Significant Stock Decline Amid Broader Market Challenges  Markets Mojo

Indoco Remedies Faces Significant Stock Decline Amid Broader Market Challenges - Markets Mojo

Click here to get full coverage on Indoco Remedies Share Price Hits Over One–Month High After Announcing Partnership With UK Distributor - NDTV Profit

Indoco Remedies Share Price Hits Over One–Month High After Announcing Partnership With UK Distributor  NDTV Profit

Indoco Remedies Share Price Hits Over One–Month High After Announcing Partnership With UK Distributor - NDTV Profit

Click here to get full coverage on Indoco Remedies Standalone June 2025 Net Sales at Rs 392.53 crore, down 2.22% Y-o-Y - Moneycontrol

Indoco Remedies Standalone June 2025 Net Sales at Rs 392.53 crore, down 2.22% Y-o-Y  Moneycontrol

Indoco Remedies Standalone June 2025 Net Sales at Rs 392.53 crore, down 2.22% Y-o-Y - Moneycontrol

Click here to get full coverage on Indoco Remedies enters into sale and lease back for its movable properties - Business Standard

Indoco Remedies enters into sale and lease back for its movable properties  Business Standard

Indoco Remedies enters into sale and lease back for its movable properties - Business Standard

Click here to get full coverage on RGP protests outside Indoco Remedies over out-of-state hiring - TheGoan

RGP protests outside Indoco Remedies over out-of-state hiring  TheGoan

RGP protests outside Indoco Remedies over out-of-state hiring - TheGoan

Click here to get full coverage on INDOCO PARTNERS WITH CLARITY PHARMA FOR DISTRIBUTION - ICICI Direct

INDOCO PARTNERS WITH CLARITY PHARMA FOR DISTRIBUTION  ICICI Direct

INDOCO PARTNERS WITH CLARITY PHARMA FOR DISTRIBUTION - ICICI Direct

Click here to get full coverage on Indoco Remedies gains final ANDA approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg - Express Pharma

Indoco Remedies gains final ANDA approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg  Express Pharma

Indoco Remedies gains final ANDA approval for Rivaroxaban Tablets USP, 2.5 mg, 10 mg, 15 mg and 20 mg - Express Pharma

Click here to get full coverage on Indoco Remedies reports consolidated net loss of Rs 35.79 crore in the June 2025 quarter - Business Standard

Indoco Remedies reports consolidated net loss of Rs 35.79 crore in the June 2025 quarter  Business Standard

Indoco Remedies reports consolidated net loss of Rs 35.79 crore in the June 2025 quarter - Business Standard

Click here to get full coverage on Indoco Remedies Faces Evaluation Shift Amid Ongoing Financial Challenges and Mixed Performance - Markets Mojo

Indoco Remedies Faces Evaluation Shift Amid Ongoing Financial Challenges and Mixed Performance  Markets Mojo

Indoco Remedies Faces Evaluation Shift Amid Ongoing Financial Challenges and Mixed Performance - Markets Mojo

Click here to get full coverage on Indoco Remedies shares fall over 7% after Goa unit gets USFDA Warning Letter - CNBC TV18

Indoco Remedies shares fall over 7% after Goa unit gets USFDA Warning Letter  CNBC TV18

Indoco Remedies shares fall over 7% after Goa unit gets USFDA Warning Letter - CNBC TV18

Click here to get full coverage on Indoco Remedies Share Price Plummets As Goa Facility Receives USFDA Warning - NDTV Profit

Indoco Remedies Share Price Plummets As Goa Facility Receives USFDA Warning  NDTV Profit

Indoco Remedies Share Price Plummets As Goa Facility Receives USFDA Warning - NDTV Profit

Click here to get full coverage on Indoco Remedies reports standalone net loss of Rs 26.24 crore in the March 2025 quarter - Business Standard

Indoco Remedies reports standalone net loss of Rs 26.24 crore in the March 2025 quarter  Business Standard

Indoco Remedies reports standalone net loss of Rs 26.24 crore in the March 2025 quarter - Business Standard

Click here to get full coverage on Buy Sun Pharma, Cipla; Hold Lupin, Indoco Among Other Pharma Stocks, Says Systematix Ahead Of Q4 Results - NDTV Profit

Buy Sun Pharma, Cipla; Hold Lupin, Indoco Among Other Pharma Stocks, Says Systematix Ahead Of Q4 Results  NDTV Profit

Buy Sun Pharma, Cipla; Hold Lupin, Indoco Among Other Pharma Stocks, Says Systematix Ahead Of Q4 Results - NDTV Profit

Click here to get full coverage on Indoco Remedies arm launches heart attack drug Ticagrelor filmcoated in UK - Medical Dialogues

Indoco Remedies arm launches heart attack drug Ticagrelor filmcoated in UK  Medical Dialogues

Indoco Remedies Limited (INDOCO)

Price Chart

Key Statistics

Technicals

About INDOCO

Latest News

Indoco Remedies Shows Strong Rebound Amid Broader Small-Cap Market Gains - Markets Mojo

Indoco Remedies AGM Approves ₹0.20 Final Dividend Per Share - TradingView

Here's Why Shareholders Should Examine Indoco Remedies Limited's (NSE:INDOCO) CEO Compensation Package More Closely - simplywall.st

Advanced Charts

Top Gainers

Top Losers